These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 29027056

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Baicalein attenuates α-synuclein aggregation, inflammasome activation and autophagy in the MPP+-treated nigrostriatal dopaminergic system in vivo.
    Hung KC, Huang HJ, Wang YT, Lin AM.
    J Ethnopharmacol; 2016 Dec 24; 194():522-529. PubMed ID: 27742410
    [Abstract] [Full Text] [Related]

  • 7. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
    Sharma N, Nehru B.
    Mol Neurobiol; 2016 Jul 24; 53(5):3326-3337. PubMed ID: 26081143
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation.
    Sharma N, Nehru B.
    Neurochem Int; 2015 Aug 24; 87():92-105. PubMed ID: 26055970
    [Abstract] [Full Text] [Related]

  • 9. Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis.
    Anusha C, Sumathi T, Joseph LD.
    Chem Biol Interact; 2017 May 01; 269():67-79. PubMed ID: 28389404
    [Abstract] [Full Text] [Related]

  • 10. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
    Febbraro F, Andersen KJ, Sanchez-Guajardo V, Tentillier N, Romero-Ramos M.
    Exp Neurol; 2013 Sep 01; 247():45-58. PubMed ID: 23531432
    [Abstract] [Full Text] [Related]

  • 11. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
    Jayaraj RL, Beiram R, Azimullah S, Meeran MFN, Ojha SK, Adem A, Jalal FY.
    Molecules; 2019 Jun 10; 24(11):. PubMed ID: 31185705
    [Abstract] [Full Text] [Related]

  • 12. The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease.
    Deng I, Garg S, Zhou XF, Bobrovskaya L.
    Front Biosci (Schol Ed); 2022 May 07; 14(2):13. PubMed ID: 35730438
    [Abstract] [Full Text] [Related]

  • 13. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
    Mandel S, Maor G, Youdim MB.
    J Mol Neurosci; 2004 May 07; 24(3):401-16. PubMed ID: 15655262
    [Abstract] [Full Text] [Related]

  • 14. Formation and Implications of Alpha-Synuclein Radical in Maneb- and Paraquat-Induced Models of Parkinson's Disease.
    Kumar A, Leinisch F, Kadiiska MB, Corbett J, Mason RP.
    Mol Neurobiol; 2016 Jul 07; 53(5):2983-2994. PubMed ID: 25952542
    [Abstract] [Full Text] [Related]

  • 15. Gallic Acid Attenuated LPS-Induced Neuroinflammation: Protein Aggregation and Necroptosis.
    Liu YL, Hsu CC, Huang HJ, Chang CJ, Sun SH, Lin AM.
    Mol Neurobiol; 2020 Jan 07; 57(1):96-104. PubMed ID: 31832973
    [Abstract] [Full Text] [Related]

  • 16. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
    Chen G, Liu J, Jiang L, Ran X, He D, Li Y, Huang B, Wang W, Fu S.
    Int J Mol Sci; 2017 Dec 21; 19(1):. PubMed ID: 29267220
    [Abstract] [Full Text] [Related]

  • 17. Pro-inflammatory cytokine-mediated ferroportin down-regulation contributes to the nigral iron accumulation in lipopolysaccharide-induced Parkinsonian models.
    Zhang Z, Hou L, Song JL, Song N, Sun YJ, Lin X, Wang XL, Zhang FZ, Ge YL.
    Neuroscience; 2014 Jan 17; 257():20-30. PubMed ID: 24183966
    [Abstract] [Full Text] [Related]

  • 18. Biochanin A Protects Against Lipopolysaccharide-Induced Damage of Dopaminergic Neurons Both In Vivo and In Vitro via Inhibition of Microglial Activation.
    Wang J, Wu WY, Huang H, Li WZ, Chen HQ, Yin YY.
    Neurotox Res; 2016 Oct 17; 30(3):486-98. PubMed ID: 27417698
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system.
    Kuter KZ, Śmiałowska M, Ossowska K.
    Pharmacol Rep; 2022 Feb 17; 74(1):67-83. PubMed ID: 34762280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.